The role and mechanism of RBM3 in sepsis brain injury

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100050990

Enrollment

Unknown

Registered

2021-09-09

Start date

2021-10-01

Completion date

Unknown

Last updated

2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

septic encephalopathy group:Nil

healthy control group:Nil

Eligibility

Sex/Gender

All

Age

46 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Septic encephalopathy group: adult patients who meet the diagnostic criteria for septic encephalopathy and agree to join this study. 2. Control group: healthy adults without underlying diseases who agree to join this study.

Exclusion criteria

Exclusion criteria: 1. Septic encephalopathy group: aged < 18 years; pregnant women; advanced tumors, etc. 2. Control group: aged < 18 years; pregnant women; tumors, etc.

Design outcomes

Primary

Measure	Time frame
RBM3;	—

Countries

China

Contacts

Public ContactWang Maohua

Affiliated Hospital of Southwest Medical University

wangmaohua@swmu.edu.cn+86 18989131360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026